SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-182549
Filing Date
2024-07-23
Accepted
2024-07-23 06:06:57
Documents
19
Period of Report
2024-07-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d873880d8k.htm   iXBRL 8-K 35399
2 EX-4.1 d873880dex41.htm EX-4.1 77048
3 EX-4.2 d873880dex42.htm EX-4.2 79511
4 EX-4.3 d873880dex43.htm EX-4.3 75209
5 EX-5.1 d873880dex51.htm EX-5.1 15459
6 EX-10.1 d873880dex101.htm EX-10.1 172359
10 GRAPHIC g873880g0722220513587.jpg GRAPHIC 2409
  Complete submission text file 0001193125-24-182549.txt   705530

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA rani-20240722.xsd EX-101.SCH 2877
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rani-20240722_lab.xml EX-101.LAB 17978
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rani-20240722_pre.xml EX-101.PRE 11276
21 EXTRACTED XBRL INSTANCE DOCUMENT d873880d8k_htm.xml XML 3650
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40672 | Film No.: 241132848
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)